Emerging research underscores the critical need to protect compounded bioidentical hormones. Action Alert!
Almost six million Americans suffer from Alzheimer’s disease, and it is projected to afflict many more in coming years. Big Pharma has been unable to produce drugs that treat this debilitating disease. New research, however, is suggesting that Alzheimer’s is more complex than previously thought, requiring an individualized approach that can include hormone replacement therapy. Unfortunately, the FDA is poised to eliminate consumer access to compounded, bioidentical hormones. We must continue to voice opposition to a ban on these important treatments.
Leading the charge on this new approach is Dr. Dale Bredesen (here is a link to his book on Amazon). The prevailing wisdom about Alzheimer’s is that it is caused by buildup of amlyloid plaque in the brain. Drug trials have been targeted at removing these plaques. But according to Dr. Bredesen and his colleagues, this is wrong. Dr. Bredesen has suggested that the buildup of amlyloid plaque is a symptom, rather than the cause of Alzheimer’s.